Gentle Giant Award – Professor Roger Guillemin, M.D., Ph.D.
Immediate past President of the
Salk Institute of La Jolla, CA.
2010 Gentle Giant Award Recipient
One of these hormones, called growth-hormone releasing factor, is used to treat growth deficiencies in children; another, called somatostatin, is used to control tumors of the pituitary gland. Dr. Guillemin was also among the first to isolate endorphins, brain molecules known to act as natural opiates. Following the isolation of endorphins, his work with cellular growth factors (CGFs), in addition to inhibins and activins, led to the recognition of multiple physiological functions and developmental mechanisms.
Since his retirement from the active pursuit of science in 1989, Dr. Guillemin has shifted his long-standing expertise with computers from science to art.